Citations

Showing 10 of 108081 citations.

Room to Grow—What is the Current Role of Neuromodulation in Pediatric Bowel-Bladder Dysfunction?
Zigelmann, Matthew J., Reinberg, Yuri

Mayo Clinic

Journal of Urology | June 20, 2017 | Volume: 198 | Issue: 3 | Pages: 498-499

10.1016/j.juro.2017.06.064 | PMID 28641087 Get It

Characterising cis -regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues
Lykke‐Andersen, Søren , Zhu, Bin , Xiao, Wenming , Hoskins, Jason W. , Zhang, Xijun , Rost, Lauren M., Collins, Irene , Bunt, Martijn van de , Jia, Jinping , Song, Lei , Jermusyk, Ashley , Chung, Charles C., Zhou, Weiyin , Matters, Gail L. , Kurtz, Robert C. , Jensen, Torben Heick , Brown, Kevin M., Ongen, Halit , Bamlet, William R. , Murray, Bradley A., McCarthy, Mark I. , Chatterjee, Nilanjan , Wolpin, Brian M. , Petersen, Gloria M. , Shi, Jianxin , Ámundadóttir, Laufey T. , Amundadottir, Laufey , Zhang, Mingfeng , Jia, Jinping, Parikh, Hemang M. , Zhang, Tongwu , Yeager, Meredith , Chanock, Stephen Jacob , Smith, Jill Palmer , Olson, Sara H. , Bamlet, William R , McCarthy, Mark I , Hoskins, Jason W

Mayo Clinic

Gut | June 20, 2017 | Volume: 67 | Issue: 3 | Pages: 521-533

10.1136/gutjnl-2016-313146 | PMID 28634199 Get It

Objective To elucidate the genetic architecture of gene expression in pancreatic tissues. Design We performed expression quantitative trait locus (eQTL) analysis in histologically normal pancreatic tissue samples (n=95) using RNA sequencing and the corresponding 1000 genomes imputed germline genotypes. Data from pancreatic tumour-derived tissue samples (n=115) from The Cancer Genome Atlas were included for comparison. Results We identified 38 615 cis -eQTLs (in 484 genes) in histologically normal tissues and 39 713 cis -eQTL (in 237 genes) in tumour-derived tissues (false discovery rate <0.1), with the strongest effects seen near transcriptional start sites. Approximately 23% and 42% of genes with significant cis -eQTLs appeared to be specific for tumour-derived and normal-derived tissues, respectively. Significant enrichment of cis -eQTL variants was noted in non-coding regulatory regions, in particular for pancreatic tissues (1.53-fold to 3.12-fold, p≤0.0001), indicating tissue-specific functional relevance. A common pancreatic cancer risk locus on 9q34.2 (rs687289) was associated with ABO expression in histologically normal (p=5.8×10 −8 ) and tumour-derived (p=8.3×10 −5 ) tissues. The high linkage disequilibrium between this variant and the O blood group generating deletion variant in ABO (exon 6) suggested that nonsense-mediated decay (NMD) of the ‘O’ mRNA might explain this finding. However, knockdown of crucial NMD regulators did not influence decay of the ABO ‘O’ mRNA, indicating that a gene regulatory element influenced by pancreatic cancer risk alleles may underlie the eQTL. Conclusions We have identified cis -eQTLs representing potential functional regulatory variants in the pancreas and generated a rich data set for further studies on gene expression and its regulation in pancreatic tissues.
Clinical outcomes of HLA‐DPB1 mismatches in 10/10 HLA‐matched unrelated donor‐recipient pairs undergoing allogeneic stem cell transplant
Moyer, Ann M. , Hashmi, Shahrukh K. , Kroning, Cynthia M., Kremers, Walter K. , Goey, Steven R. De, Patnaik, Mrinal M. , Litzow, Mark R. , Gastineau, Dennis A. , Jacob, Eapen K., Kreuter, Justin D. , Wakefield, Laurie L., De Goey, Steven R, Hogan, William J. , Gandhi, Manish J. , Kremers, Walter K

Mayo Clinic

European Journal of Haematology | June 20, 2017 | Volume: 99 | Issue: 3 | Pages: 275-282

10.1111/ejh.12916 | PMID 28632323 Get It

AbstractObjectiveHLA‐DPB1 matching may impact allogeneic hematopoietic stem cell transplantation (ASCT) outcomes; however, this locus is not in linkage disequilibrium with the remainder of the HLA genes. After classifying HLA‐DPB1 mismatches based on T‐cell epitope, avoiding non‐permissive mismatches may impact survival. We tested this hypothesis at a single academic institution.MethodsRetrospective HLA‐DPB1 genotyping was performed on 153 adult patients who underwent ASCT and unrelated donors matched for HLA‐A, B, C, DRB1, and DQB1 loci (10/10). Using the ImMunoGeneTics/HLA T‐cell epitope matching algorithm, mismatch status was classified as permissive or non‐permissive.ResultsOf 153 donor‐recipient pairs, 22 (14.4%) were HLA‐DPB1 matches, 64 (42.8%) permissive mismatches, and 67 (43.8%) non‐permissive mismatches. DPB1 mismatch increased risk of chronic graft‐versus‐host disease (cGVHD; RR 2.89 [1.19‐9.53], P=.016) compared with DPB1‐matched transplants, but there were no differences in overall mortality, risk of relapse, or acute GVHD (aGVHD). Combining matches and permissive mismatches and comparing to non‐permissive mismatches, there was no significant difference in overall survival or relapse; however, patients receiving non‐permissive mismatched transplants experienced greater risk of aGVHD overall and severe aGVHD (RR 1.66 [1.13‐2.44], P=.010 and RR 1.97 [1.10‐3.59], P=.024, respectively).ConclusionIn this single‐center study, HLA‐DPB1 matching influenced outcomes of patients undergoing ASCT for hematologic malignancy.
The Efficacy of Continuous Positive Airway Pressure Therapy in Reducing Cardiovascular Events in Obstructive Sleep Apnea: A Systematic Review
Parsons, Christine, Allen, Sorcha , Parish, James M., Mookadam, Farouk , Mookadam, Martina , Firth, Christine , Parish, James

Mayo Clinic

Future Cardiology | June 20, 2017 | Volume: 13 | Issue: 4 | Pages: 397-412

10.2217/fca-2017-0004 | PMID 28631492 Get It

Needlestick Injuries in Interventional Radiology Are Common and Underreported
Prabhakar, Anand M., Naidu, Sailendra , Öklü, Rahmi , Deipolyi, Amy R. , Oklu, Rahmi

Mayo Clinic

Radiology | June 20, 2017 | Volume: 285 | Issue: 3 | Pages: 870-875

10.1148/radiol.2017170103 | PMID 28631962 Get It

Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registry
Merola, Aristide , Fasano, Alfonso , Hassan, Anhar , Ostrem, Jill L. , Contarino, Maria Fiorella , Lyons, Mark , Wolf, Marc E. , Klassen, Bryan T. , Rootselaar, Anne‐Fleur van , Regidor, Ignacio , Ondo, William G. , Guridi, Jorge , Volkmann, Jens , Shukla, Aparna Wagle , Mandybur, George, Okun, Michael S. , Witt, Karsten , Starr, Philip A. , Deuschl, Günther , Espay, Alberto J , Krauss, Joachim Kurt , Duker, Andrew , Espay, Alberto J. , Deuschl, Günther , Okun, Michael S

Mayo Clinic

Movement Disorders | June 20, 2017 | Volume: 32 | Issue: 8 | Pages: 1240-1244

10.1002/mds.27082 | PMID 28631862 Get It

AbstractBackgroundWe report the accumulated experience with ventral intermediate nucleus deep brain stimulation for medically refractory orthostatic tremor.MethodsData from 17 patients were reviewed, comparing presurgical, short‐term (0‐48 months), and long‐term (≥48 months) follow‐up. The primary end point was the composite activities of daily living/instrumental activities of daily living score. Secondary end points included latency of symptoms on standing and treatment‐related complications.ResultsThere was a 21.6% improvement (P = 0.004) in the composite activities of daily living/instrumental activities of daily living score, which gradually attenuated (12.5%) in the subgroup of patients with an additional long‐term follow‐up (8 of 17). The latency of symptoms on standing significantly improved, both in the short‐term (P = 0.001) and in the long‐term (P = 0.018). Three patients obtained no/minimal benefit from the procedure.ConclusionsDeep brain stimulation of the ventral intermediate nucleus was, in general, safe and well tolerated, yielding sustained benefit in selected patients with medically refractory orthostatic tremor. © 2017 International Parkinson and Movement Disorder Society
Management of pediatric hepatocellular carcinoma: A multimodal approach
Kohorst, Mira A. , Matsumoto, Jane M., El‐Youssef, Mounif, Arndt, Carola A.S., Rodriguez, Vilmarie , Rao, Amulya A. Nageswara , Warad, Deepti M, El-Youssef, Mounif, Nageswara Rao, Amulya A , Warad, Deepti , Heimbach, Julie K.

Mayo Clinic

Pediatric Transplantation | June 20, 2017 | Volume: 21 | Issue: 6 | Pages: No page available

10.1111/petr.13007 | PMID 28631359 Get It

AbstractHCC is rare in the pediatric population, but is the second most common liver malignancy in children. Survival rates for primary unresectable HCC have been dismal. The objective of this study was to describe our experience with a multimodal approach for the management of unresectable HCC in two adolescent patients and to review the literature. Both patients are currently alive with no recurrence at 51 and 29 months post‐transplant. Multimodality treatment involving chemotherapy with doxorubicin, cisplatin, and sorafenib; TACE; timely liver transplantation; and post‐transplant therapy with sorafenib and mTOR inhibitors may help improve outcomes and prolong survival in pediatric patients with unresectable HCC.
Will we be able to afford a cure in multiple myeloma?
Chakraborty, Rajshekhar , Gertz, Morie A. , Chakraborty, Rajshekhar

Mayo Clinic

Leukemia & Lymphoma | June 20, 2017 | Volume: 59 | Issue: 1 | Pages: 1-2

10.1080/10428194.2017.1339883 | PMID 28629244 Get It

Diagnostic Perturbations
Asirvatham, Samuel J. , Stevenson, William G. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | June 20, 2017 | Volume: 10 | Issue: 6 | Pages: No page available

10.1161/circep.117.005481 | PMID 28630176 Get It